These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2540944

  • 1. [Training of the immune system of foals against ERP virus infections by frequent vaccination with presently available commercial vaccines].
    Bürki F, Nowotny N, Rossmanith W, Pallan C, Möstl K.
    Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):162-5. PubMed ID: 2540944
    [Abstract] [Full Text] [Related]

  • 2. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR, Studdert MJ.
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [Abstract] [Full Text] [Related]

  • 3. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
    Dutta SK, Shipley WD.
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):445-8. PubMed ID: 164808
    [Abstract] [Full Text] [Related]

  • 4. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 5. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 7. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474
    [Abstract] [Full Text] [Related]

  • 8. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT, Allen GP.
    Dev Biol Stand; 1982 May 01; 52():493-8. PubMed ID: 6299858
    [Abstract] [Full Text] [Related]

  • 9. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG, Pouwels HG, van Loon AA.
    Vet J; 2004 Mar 15; 167(2):150-7. PubMed ID: 14975389
    [Abstract] [Full Text] [Related]

  • 11. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F, Nowotny N, Hofer A.
    Dtsch Tierarztl Wochenschr; 1991 Mar 15; 98(3):82-9. PubMed ID: 1646100
    [Abstract] [Full Text] [Related]

  • 12. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W.
    Tierarztl Prax; 1988 Mar 15; 16(1):61-3. PubMed ID: 2835828
    [Abstract] [Full Text] [Related]

  • 13. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 14. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS, Wagner B, Bigbie R, Hussey SB, Rao S, Morley PS, Lunn DP.
    Vaccine; 2010 Jul 19; 28(32):5203-11. PubMed ID: 20538091
    [Abstract] [Full Text] [Related]

  • 15. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):41-6. PubMed ID: 16513181
    [Abstract] [Full Text] [Related]

  • 16. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N, Bridges CG.
    Res Vet Sci; 1990 Mar 15; 48(2):235-9. PubMed ID: 2159176
    [Abstract] [Full Text] [Related]

  • 17. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ.
    J Am Vet Med Assoc; 1995 Sep 15; 207(6):698-701. PubMed ID: 7657564
    [No Abstract] [Full Text] [Related]

  • 18. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA, Mock RE, Lock TF.
    Am J Vet Res; 1980 Jul 15; 41(7):994-6. PubMed ID: 6254412
    [Abstract] [Full Text] [Related]

  • 19. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
    Bürki F, Nowotny N, Oulehla J, Schmehlik O, Möstl K, Pallan C, Rossmanith E.
    Zentralbl Veterinarmed B; 1991 Aug 15; 38(6):432-40. PubMed ID: 1659067
    [Abstract] [Full Text] [Related]

  • 20. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.